The effect of obesity on short- and long-term mortality postcoronary
revascularization: a meta-analysis.
(1) Institute of Postcoronary
Care and Arrhythmias, Department of Cardiovascular Diseases, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia; (2) Institute of Cardiology, Department of Internal Diseases, Dubrava University Hospital, Zagreb, Croatia; (3) Institute of Anesthesiology and Intensive Care, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia; (4) Institute of Cardiovascular Diseases, Department of Internal Medicine, Rijeka University Hospital Centre, Rijeka, Croatia; (5) Department of Cardiovascular Diseases, Zagreb University Hospital Centre, Zagreb, Croatia; (6) Division of Cardiology, Institute of Internal Medicine, Zadar General Hospital, Zadar, Croatia
In another prospective, randomized clinical trial, mean time of conversion was significantly shorter in the ranolazine-amiodarone group, suggesting a superior antiarrhythmic effect against postcoronary
artery bypass graft (CABG) AF compared to amiodarone alone [25,26].
Effect of obesity on short-and long-term mortality postcoronary
revascularization: a meta analysis.
Medical history was notable for coronary artery disease status postcoronary
artery bypass graft, end stage renal disease on hemodialysis, and oxygen-dependent COPD.
Microvascular alterations postcoronary
artery bypass grafting are characterized by a marked heterogeneity of perfusion reflected by the decreased proportion of perfused small vessels.
Amiodarone versus digoxin and metoprolol combination for prevention of postcoronary
bypass atrial fibrillation.
Thus, an apnea-hypopnea index (AHI) [greater than or equal to] 5 was associated with significant higher risk of postcoronary
artery bypass surgery AF compared with lower values of AHI .
Kem, "Suppression of autonomic-mediated triggered firing in pulmonary vein preparations, 24 hours postcoronary
artery ligation in dogs," Journal of Cardiovascular Electrophysiology, vol.
Women with a recent cardiac event, including myocardial infarction/ acute coronary syndrome, postcoronary
intervention (coronary artery bypass, stenting, angioplasty), angina, and heart failure, need to participate in a comprehensive risk-reduction regimen such as a cardiac rehabilitation program.
The majority or 79% of participants had a diagnosis of being status postcoronary
bypass grafting surgery (CABG), 7% had a myocardial infarction, and 14% had an aortic valve replacement.
The drug is also contraindicated for treating postcoronary
artery bypass graft surgery pain.